Page last updated: 2024-10-22

alprazolam and Hypogonadism

alprazolam has been researched along with Hypogonadism in 1 studies

Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.

Hypogonadism: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).

Research Excerpts

ExcerptRelevanceReference
" They represent an improvement compared with transdermal delivery by patches because they offer more dosage flexibility, less irritation potential and a better cosmetic appearance."2.43Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. ( Alberti, I; Carrara, DN; Grenier, A; Kraus, H, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti, I1
Grenier, A1
Kraus, H1
Carrara, DN1

Reviews

1 review available for alprazolam and Hypogonadism

ArticleYear
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
    Expert opinion on drug delivery, 2005, Volume: 2, Issue:5

    Topics: Administration, Cutaneous; Alprazolam; Animals; Anti-Anxiety Agents; Drug Delivery Systems; Estradio

2005